As of Jul 31
| +0.50 / +6.54%|
The 7 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +120.86% increase from the last price of 8.15.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.